Abstract
This article discusses the key symptom domains to be assessed in fibromyalgia. Development of a consensus on a core set of outcome measures that should be assessed and reported in all clinical trials is needed to facilitate interpretation, pooling, and comparison of results. This aligns with the key objective of the Outcome Measures in Rheumatoid Arthritis Clinical Trials initiative to improve outcome measurement in rheumatic diseases through a data-driven interactive consensus process.
| Original language | English |
|---|---|
| Pages (from-to) | 329-337 |
| Number of pages | 9 |
| Journal | Rheumatic Disease Clinics of North America |
| Volume | 35 |
| Issue number | 2 |
| DOIs | |
| State | Published - May 2009 |
Keywords
- Assessment
- Clinical trials
- Core data set
- Domains
- Fibromyalgia
Fingerprint
Dive into the research topics of 'Key Symptom Domains to Be Assessed in Fibromyalgia (Outcome Measures in Rheumatoid Arthritis Clinical Trials)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver